Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDHDS With Amiloride
NCT02122731Phase 4Completed
- Start
- Nov 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amiloride in resistant hypertension (RH). Primary endpoint: Average Daytime Systolic and Diastolic Blood Pressure at 8 weeks. Started Nov 2010; status: completed.
02
Drugs
amiloride
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02122731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122731.